Trial intelligence / Profile preview

Coenzyme Q10 in nephropathy among patients with type 2 diabetes mellitus

IRCT20130812014333N120Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of coenzyme q10 in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Kermanshah University of Medical Sciences. Started Jun 2019; status: completed.

02

Drugs

coenzyme q10
03

Conditions

diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT20130812014333N120.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130812014333N120.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call